Application 217495
- Type
- ANDA
- Sponsor
- XIROMED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | POWDER;INTRAVENOUS | 100MCG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217495-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217495-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217495-001 | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER / INTRAVENOUS | AP | 2024-11-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217495-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217495-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217495-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217495-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217495-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217495-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217495-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217495-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217495-001 | AP | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217495-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db89c58f-9dd0-b6d6-e053-2a95a90ae2e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9cb3417-e8cb-13f8-e053-2a95a90a294b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ca4634a5-d8d7-48a4-e053-2995a90a0cd4 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | dac0af5d-622c-e18c-e053-2995a90a5739 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f317a597-4644-746a-e053-2995a90a807f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e0503b8c-7eb7-269e-e053-2995a90a1bca | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e08c2af4-c20a-3176-e053-2a95a90a1aa9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | e3d949ce-731b-6dfe-e053-2a95a90a0074 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31b5d54-7536-4290-e053-2a95a90ac235 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f32b4a01-edea-fc85-e053-2995a90ac175 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db998119-a293-3568-e053-2995a90ac47a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | d9dfd5b8-06a5-2728-e053-2995a90a298e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | fa15ac73-f4f6-7a6b-e053-6294a90a4f4e | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31a35cb-fc54-8872-e053-2a95a90ad8e7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31ba297-e042-187a-e053-2a95a90a4861 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f31d987d-6836-b4a7-e053-2a95a90a8f7b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86e74e1-0d55-8d0e-e053-6394a90a07bf | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | f86efc89-f784-c8bb-e053-6294a90a63c9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | db9821db-3fe3-d1cf-e053-2a95a90a0252 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine Sodium LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | da570872-94a1-4852-e053-2995a90aacb6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Levothyroxine sodium LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.